scispace - formally typeset
M

Marco Contoli

Researcher at University of Ferrara

Publications -  157
Citations -  5841

Marco Contoli is an academic researcher from University of Ferrara. The author has contributed to research in topics: COPD & Asthma. The author has an hindex of 30, co-authored 135 publications receiving 4766 citations. Previous affiliations of Marco Contoli include National Institutes of Health & Imperial College Healthcare.

Papers
More filters
Journal ArticleDOI

Role of deficient type III interferon-λ production in asthma exacerbations

TL;DR: In this paper, the authors show deficient induction of interferon-λs by rhinovirus in primary bronchial epithelial cells and alveolar macrophages, which was highly correlated with severity of rhinovirus induced asthma exacerbation and virus load in experimentally infected human volunteers.
Journal ArticleDOI

Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production.

TL;DR: Increased RV-induced clinical illness severity in asthmatic compared with normal subjects is demonstrated, evidence of strong relationships between virus load, lower airway virus-induced inflammation and asthma exacerbation severity is provided, and indicates augmented Th2 or impaired Th1 or IL-10 immunity are likely important mechanisms.
Journal ArticleDOI

Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation

TL;DR: A new model of COPD exacerbation is developed that strongly supports a causal relationship between rhinovirus infection and COPD alleviation and impaired IFN production and neutrophilic inflammation may be important mechanisms in virus-induced COPd exacerbations.
Journal ArticleDOI

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients

TL;DR: Increased expression of the Th17‐related cytokines IL‐17A, IL‐22 and IL‐23 in COPD patients may reflect their involvement, and that of specific IL‐ 17‐producing cells, in driving the chronic inflammation seen in COPd.